triazoles has been researched along with mk-0916 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cilissen, C; Crumley, TM; Gottesdiener, KM; Hermanowski-Vosatka, A; Lai, E; Langdon, RB; Ramael, S; Stone, JA; Sun, L; Wagner, JA; Wenning, L; Wright, DH; Yan, K; Yang, AY; Zheng, W | 1 |
| Andersén, H; Bohlooly-Y, M; Cottrell, EC; Denn, M; DeSchoolmeester, J; Goldberg, FW; Gutierrez, PM; Harno, E; Leighton, B; Swales, JG; Turnbull, AV; White, A; Wild, MJ; Yu, A | 1 |
1 trial(s) available for triazoles and mk-0916
| Article | Year |
|---|---|
Pharmacokinetic-pharmacodynamic studies of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor MK-0916 in healthy subjects.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adolescent; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Female; Healthy Volunteers; Humans; Male; Middle Aged; Models, Biological; Triazoles; Young Adult | 2013 |
1 other study(ies) available for triazoles and mk-0916
| Article | Year |
|---|---|
11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors still improve metabolic phenotype in male 11β-HSD1 knockout mice suggesting off-target mechanisms.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adipose Tissue; Animals; Blood Glucose; Body Weight; Brain; Dietary Fats; Dose-Response Relationship, Drug; Energy Metabolism; Female; Gene Expression Regulation, Enzymologic; Genotype; Glucose; Hypoglycemic Agents; Insulin; Liver; Male; Mice; Mice, Knockout; Molecular Structure; Pyrazoles; Pyrimidines; RNA, Messenger; Triazoles | 2013 |